Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
Sponsor: Cancer Trials Ireland
A observational or N/A phase clinical study on Breast Cancer and HER2 Negative Breast Cancer, this trial is completed. The trial is conducted by Cancer Trials Ireland and has accumulated 12 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Aug 2025 — Present [monthly]
Completed
-
Sep 2024 — Aug 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2021 — Nov 2023 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Trials Ireland
For direct contact, visit the study record on ClinicalTrials.gov .